R2 was a factorial randomization resulting in four arms: high-dose methotrexate (HDM) with pulses ... The trial was monitored by an independent data monitoring committee that reviewed safety and ...

Study participants were randomly assigned to receive aflibercept 8mg every 8 weeks following 3 initial monthly doses; aflibercept 8mg every 8 weeks following 5 initial monthly doses; or Eylea ...

In the D‑Lay MS randomized clinical trial, investigators conducted a parallel, double‑blind, placebo‑controlled study comparing high‑dose cholecalciferol versus placebo in untreated CIS.

But the Swiss company can check one potential solution off its list as a phase 3 trial of its high-dose version of Ocrevus in patients with relapsing multiple sclerosis (RMS) has failed to move ...

Symptoms may include a high fever, cough ... professional has advised the extra supplement and is monitoring their care, taking doses of vitamins greater than the recommended daily amount can ...

In the current study they evaluated the therapeutic potential of human MSC-EVs in mice exposed to high-dose total body irradiation. MSC-EV administration significantly enhanced survival ...

Symptoms may include a high fever, cough ... professional has advised the extra supplement and is monitoring their care, taking doses of vitamins greater than the recommended daily amount can ...

The use of high-dose methotrexate (HD-MTX) has improved survival rates. This article describes the experience of a patient treated with HD-MTX and outlines the essential aspects of care for the ...

Among those who adhered to treatment, the high-dose group achieved an average weight loss of 20.7%, compared to 17.5% with the lower dose and 2.4% in the placebo group. For the overall group ...

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study suggests that supplementing it in high doses could help reduce symptoms.

It should come as no surprise that Netflix’s Adolescence shot to the top of the Nielsen charts during the week ... including new weekly high of 876M minutes viewed for Severance with the release ...

The MUSETTE trial found no additional benefit in higher doses of ocrelizumab for RMS compared ... infrastructure or capacity for IV delivery. A high-concentration formula designed for on-body ...